Medicine and Dentistry
Diseases
100%
Systematic Review
96%
Neoplasm
69%
Meta-Analysis
59%
Cohort Analysis
52%
COVID-19
52%
Quality of Life
50%
Randomized Controlled Trial
46%
Malignant Neoplasm
45%
Health Care Cost
43%
Magnetic Resonance Imaging
42%
Pediatrics
40%
Prevalence
37%
Overall Survival
35%
Biological Marker
34%
Prostate Cancer
32%
Infection
30%
Odds Ratio
29%
Hazard Ratio
28%
Breast Cancer
26%
Clinical Trial
26%
Radiation Therapy
26%
Recurrent Disease
24%
Apoplexy
23%
Congestive Heart Failure
22%
Cost-Effectiveness Analysis
22%
Adverse Event
21%
Computer Assisted Tomography
21%
Prospective Cohort Study
21%
Observational Study
20%
Decision Making
19%
Colorectal Carcinoma
19%
Health Care
19%
Clinician
19%
Lung
19%
Biopsy Technique
19%
Body Mass Index
19%
Patient-Reported Outcome
18%
Cardiovascular System
18%
Cardiovascular Disease
18%
Cancer
17%
Severe Acute Respiratory Syndrome Coronavirus 2
17%
Cross Sectional Study
17%
Retrospective Cohort Study
17%
Arm
17%
Intensive Care Unit
16%
Logistic Regression Analysis
16%
Metastatic Carcinoma
15%
Bleeding
15%
Surgeon
15%
Mental Health
15%
Brain Ischemia
14%
Kidney Transplantation
14%
Osteoarthritis
14%
In Vitro
14%
Melanoma
14%
Primary Health Care
14%
Liver Transplantation
13%
Pancreas Cancer
13%
Placebo
13%
Cholangiocarcinoma
13%
Percutaneous Aortic Valve Replacement
13%
Patient Referral
13%
Disease
13%
Kidney Graft
12%
Medicine
12%
Inflammatory Bowel Disease
12%
Comorbidity
12%
Randomized Clinical Trial
12%
Ganglioglioma
11%
Atrial Fibrillation
11%
Public Health
11%
Chemoradiotherapy
11%
Diabetes
11%
Blood Pressure
10%
Proportional Hazards Model
10%
Human Immunodeficiency Virus
10%
Health Outcomes
10%
Cohort Effect
10%
Traumatic Brain Injury
10%
Oncology
10%
Rectum Cancer
10%
Progression Free Survival
10%
Intensive Care
9%
Combination Therapy
9%
Retrospective Study
9%
Lung Cancer
9%
Neuroendocrine Tumor
9%
T Cell
9%
Percutaneous Coronary Intervention
9%
Organoid
9%
Chronic Kidney Disease
9%
Esophagectomy
9%
Cervical Cancer
9%
Awareness
9%
Triage
9%
Acute Myeloid Leukemia
9%
Coronary Artery Disease
9%
Systemic Therapy
9%
Non Small Cell Lung Cancer
9%
Pharmacology, Toxicology and Pharmaceutical Science
Diseases
77%
Neoplasm
41%
Malignant Neoplasm
36%
Cohort Study
34%
Pharmacokinetics
33%
Infection
29%
Prevalence
25%
Randomized Controlled Trial
25%
Biological Marker
25%
Overall Survival
22%
Clinical Trial
22%
Adverse Event
22%
Congestive Heart Failure
20%
Chemotherapy
19%
Placebo
18%
Prostate Cancer
16%
SARS Coronavirus
14%
Breast Cancer
14%
Cardiovascular Disease
14%
Recurrent Disease
13%
Receptor
12%
Observational Study
11%
Cerebrovascular Accident
11%
Syndrome
11%
Inflammation
11%
Progression Free Survival
11%
Prospective Cohort Study
10%
Combination Therapy
10%
Inflammatory Arthritis
9%
Colorectal Carcinoma
9%
Rheumatoid Arthritis
9%
Comorbidity
9%
Non Small Cell Lung Cancer
9%
Bleeding
9%
Side Effect
8%
Coronavirinae
8%
Randomized Clinical Trial
8%
Heart Infarction
8%
Atrial Fibrillation
8%
Pandemic
8%
Remission
8%
All Cause Mortality
7%
Pharmacotherapy
7%
Chemoradiation Therapy
7%
HIV
7%
Pharmacodynamics
7%
Melanoma
7%
Inflammatory Bowel Disease
7%
Monotherapy
7%
Asthma
6%
Non Insulin Dependent Diabetes Mellitus
6%
Therapeutic Drug Monitoring
6%
Antibiotics
6%
Cross-Sectional Study
6%
Retrospective Study
6%
Immunotherapy
6%
Osteoarthritis
6%
Pancreas Cancer
6%
Tumor Necrosis Factor
6%
Brain Ischemia
5%
Acute Myeloid Leukemia
5%
Migraine
5%
Cardiovascular Risk
5%
Lung Cancer
5%
Solid Malignant Neoplasm
5%
Coronary Artery Disease
5%
Prospective Study
5%
Messenger RNA
5%
Liver Cell Carcinoma
5%
Chronic Kidney Failure
5%
Disease Exacerbation
5%
Glioblastoma
5%
Traumatic Brain Injury
5%
Haemophilia A
5%
Irinotecan
5%
Low Back Pain
5%
Prematurity
5%
Neuroendocrine Tumor
5%